Searched for
GERMAN DRUG GIANT
European shares rise as Inditex leads retailers, Novo Nordisk shinesEuropean shares experienced a rise, propelled by strong performances in the retail sector, particularly Inditex, which reported accelerated...- ‘Griselda’ miniseries debuting on Netflix. Here’s everything you may want to knowA mini-biographical series surrounding Griselda Blanco and Sofia Vergara is coming to Netflix soon.
- Could cancer vaccines become a reality? Here’s what experts sayA cancer vaccine could be a reality in a few years, according to the co-founders of BioNTech, a German company, which also manufactured the...
- Amid Covid vaccine success, BioNTech plans to return €2bn to shareholdersAfter the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...
- Dr Reddy's Labs launches copy of BI drug; move may lead to legal battleUnder its brand Vicra, Dr. Reddy's is expected to sell the drug in India at less than a third of the price charged by Boehringer Ingelheim....
- Pfizer/BioNTech to supply vaccines for Olympic athletes"Delivery of initial doses to participating delegations is expected to begin at the end of May where possible with the aim to ensure partic...
- Saudi announces three-phase roll out of Covid-19 vaccinePeople aged over 65 as well as those with chronic ailments or at a high risk of infection will receive the vaccine in the first stage, and ...
- Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' statusTwo experimental coronavirus vaccines jointly developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer have received ...
- Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant NovartisHere’s everything that you need to know about the doctor-turned-CEO.
- Delhi High Court favours Natco, Alembic; allows them to export generics of Bayer's drugsBayer had approached court in 2016 to stop Alembic Pharmaceuticals from exporting its generic of the German company's blood thinner brand '...
- Aurobindo Pharma may buy Portugal's Generis, deal likely to be valued at $200 millionAurobindo's latest bid comes on the heels of last month’s shot at Israeli drug maker Teva's UK product portfolio, where it was outbid by ri...
- Boehringer Ingelheim India and Lupin enter agreement to market diabetes drugIMS values the Indian diabetes market is at Rs9,003 crore and has recorded it as growing at 19.5%, according to a release by Lupin.
- Battle over stroke medicine between Boehringer and Gennova heats up at courtGennova didn’t follow the ethical guidelines issued by the Indian Council of Medical Research (ICMR) while designing its clinical study for...
- Delhi High Court defers order blocking Gennova’s stroke drugGennova's drug can't be approved as a biosimilar of tenecteplase as the original drug isn't prescribed for strokes, argued P Chidambaram, c...
- Sanofi, Boehringer Ingelheim seek CCI nod for $25-billion global asset swap dealThe commission will review if the two companies swapping their businesses will cause any adverse impact on the local competition.
- Dr Reddy's, Merck to jointly develop biosimilarsmanufacturing of the compounds and will lead phase-III development.
- Piramal acquires Decision Resources Group, US analytics company, for $635 mnPiramal bought DRG from private equity firm Providence, which exited the company by selling its 100% holding.
- Cipla, PEs team up for Merck's bizRanbaxy Lab, Teva Corp, Actavis and Mylan are among the cos short listed in the first round.
- Indian bidders may find Merck bitter pillEven as domestic drug majors, Ranbaxy and Cipla, submitted their bids on Monday for acquiring German drug giant Merck's generics business.
- Ranbaxy, Wockhardt eye 3M pharma bizRanbaxy and Wockhardt and a PE player are eyeing 3M's pharmaceutical division for over $1 bn.
Load More
